Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012)
Bausch Health Companies' (BHC) quarterly Amortizatization of Intangibles came in at $3.2 million in Q1 2012, up 22.98% year-on-year from $2.6 million in Q2 2011, and up 63.51% quarter-over-quarter from $2.0 million in Q4 2011.
Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012) Analysis & Trends
Bausch Health Companies has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $3.2 million for Q1 2012.
- Amortizatization of Intangibles for Q1 2012 came in at $3.2 million, up 22.98% year-over-year; the trailing twelve-month figure through Mar 2012 was $9.1 million (down 17.37% YoY), and the FY2011 annual result was $8.5 million, down 23.98% from the prior year.
- Amortizatization of Intangibles came in at $3.2 million for Q1 2012 at Bausch Health Companies, up from $2.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q1 2012 to a low of $564000.0 in Q2 2009.
- The 4-year median for Amortizatization of Intangibles is $2.7 million (2009), against an average of $2.4 million.
- Across the five-year window, Amortizatization of Intangibles jumped 403.01% in 2010 and slumped 31.44% in 2011, its largest moves.
- Bausch Health Companies' Amortizatization of Intangibles stood at $2.7 million in 2009, then increased by 2.88% to $2.8 million in 2010, then decreased by 29.51% to $2.0 million in 2011, then surged by 63.51% to $3.2 million in 2012.
- The last three Amortizatization of Intangibles figures came in at $3.2 million (Q1 2012), $2.0 million (Q4 2011), and $1.9 million (Q3 2011), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Bausch Health Companies | 1.92 Bn | 1.58 Bn | 2.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 3.25 Mn |
| Mar 31, 2012 | 3.25 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Sep 30, 2011 | 1.92 Mn |
| Sep 30, 2011 | 1.92 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Mar 31, 2011 | 2.64 Mn |
| Mar 31, 2011 | 2.64 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Sep 30, 2010 | 2.71 Mn |
| Sep 30, 2010 | 2.71 Mn |
| Jun 30, 2010 | 2.84 Mn |
| Jun 30, 2010 | 2.84 Mn |
| Mar 31, 2010 | 2.80 Mn |
| Mar 31, 2010 | 2.80 Mn |
| Dec 31, 2009 | 2.74 Mn |
| Dec 31, 2009 | 2.74 Mn |